Immunochemical	O
differences	O
between	O
glucocorticoid	B-protein
receptors	I-protein
from	O
corticoid-sensitive	B-cell_type
and	I-cell_type
-resistant	I-cell_type
malignant	I-cell_type
lymphocytes	I-cell_type
.	O

We	O
have	O
explored	O
the	O
possibility	O
of	O
using	O
antibodies	B-protein
against	O
purified	O
rat	O
liver	O
glucocorticoid	B-protein
receptors	I-protein
to	O
study	O
the	O
immunochemical	O
properties	O
of	O
glucocorticoid	B-protein
receptors	I-protein
from	O
murine	B-cell_type
and	I-cell_type
human	I-cell_type
malignant	I-cell_type
lymphocytes	I-cell_type
.	O

For	O
this	O
purpose	O
,	O
purified	B-protein
immune	I-protein
immunoglobulin	I-protein
G	I-protein
was	O
covalently	O
linked	O
to	O
Sepharose	B-protein
CL-4B	I-protein
.	O

We	O
then	O
examined	O
the	O
ability	O
of	O
the	O
affinity	O
gel	O
to	O
recognize	O
cytosolic	B-protein
[	I-protein
3H	I-protein
]	I-protein
triamcinolone	I-protein
acetonide-receptor	I-protein
complexes	I-protein
from	O
the	O
corticoid-sensitive	B-cell_line
(	I-cell_line
CS	I-cell_line
)	I-cell_line
and	I-cell_line
-resistant	I-cell_line
strains	I-cell_line
of	I-cell_line
mouse	I-cell_line
lymphoma	I-cell_line
P1798	I-cell_line
,	O
from	O
CS	B-cell_type
lymphocytes	I-cell_type
of	O
patients	O
with	O
chronic	O
lymphatic	O
leukemia	O
,	O
and	O
from	O
a	O
CS	B-cell_line
clone	I-cell_line
of	O
human	B-cell_type
leukemic	I-cell_type
lymphoblasts	I-cell_type
in	O
tissue	O
culture	O
(	O
CH6	B-cell_line
)	O
.	O

Mouse	O
thymus	O
was	O
used	O
as	O
a	O
source	O
of	O
glucocorticoid	B-protein
receptor	I-protein
from	O
normal	B-cell_type
CS	I-cell_type
lymphocytes	I-cell_type
.	O

Whereas	O
the	O
immunoaffinity	O
column	O
retained	O
70	O
to	O
84	O
%	O
of	O
the	O
58-	O
to	O
62-A	O
(	O
Stokes	O
radius	O
)	O
[	B-protein
3H	I-protein
]	I-protein
triamcinolone	I-protein
acetonide-receptor	I-protein
complexes	I-protein
characteristic	O
of	O
the	O
CS	B-cell_line
mouse	I-cell_line
and	I-cell_line
human	I-cell_line
lymphocytes	I-cell_line
,	O
it	O
failed	O
to	O
recognize	O
the	O
27-	O
to	O
28-A	O
(	O
Stokes	O
radius	O
)	O
glucocorticoid	B-protein
receptor	I-protein
present	O
in	O
corticoid-resistant	O
mouse	B-cell_line
lymphoma	I-cell_line
P1798	I-cell_line
cells	I-cell_line
.	O

Therefore	O
,	O
under	O
appropriate	O
experimental	O
conditions	O
,	O
it	O
was	O
possible	O
to	O
demonstrate	O
cross-reactivity	O
between	O
the	O
antiserum	O
against	O
rat	B-protein
liver	I-protein
glucocorticoid	I-protein
receptor	I-protein
and	O
the	O
58-	O
to	O
62-A	O
(	O
Stokes	O
radius	O
)	O
glucocorticoid	B-protein
receptor	I-protein
from	O
species	O
as	O
diverse	O
as	O
mouse	O
and	O
humans	O
.	O

[	NULL
CANCER	NULL
RESEARCH	NULL
41	NULL
,	NULL
134-137	NULL
,	NULL
January	NULL
1981	NULL
]	NULL
0008-5472/81/0041-0000	NULL
$	NULL
02.00	NULL
Immunochemical	NULL
Differences	NULL
between	NULL
Glucocorticoid	NULL
Receptors	NULL
from	NULL
Corticoid-sensitive	NULL
and	NULL
-resistant	NULL
Malignant	NULL
Lymphocytes	NULL
'	NULL
John	NULL
Stevens	NULL
,	NULL
``	NULL
Howard	NULL
J.	NULL
Eisen	NULL
,	NULL
Yee-Wan	NULL
Stevens	NULL
,	NULL
Harriette	NULL
Haubenstock	NULL
,	NULL
Robert	NULL
L.	NULL
Rosenthal	NULL
,	NULL
and	NULL
Alexander	NULL
Artishevsky	NULL
Research	NULL
Institute	NULL
[	NULL
J.	NULL
S.	NULL
,	NULL
Y-W.	NULL
S.	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL
]	NULL

and	NULL
Department	NULL
of	NULL
Medicine	NULL
[	NULL
R.	NULL
L.	NULL
R.	NULL
}	NULL
,	NULL
Joint	NULL
Diseases	NULL
North	NULL
General	NULL
Hospital	NULL
,	NULL
Mount	NULL
Sinai	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
York	NULL
,	NULL
New	NULL
York	NULL
10035	NULL
,	NULL
and	NULL
Developmental	NULL
Pharmacology	NULL
Branch	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Child	NULL
Health	NULL
and	NULL
Human	NULL
Development	NULL
,	NULL
NIH	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20205	NULL
[	NULL
H.	NULL
J.	NULL
E	NULL
]	NULL
ABSTRACT	NULL
We	NULL
have	NULL
explored	NULL
the	NULL
possibility	NULL
of	NULL
using	NULL
antibodies	NULL
against	NULL
purified	NULL
rat	NULL
liver	NULL
glucocorticoid	NULL
receptors	NULL
to	NULL
study	NULL
the	NULL
immunochemical	NULL
properties	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
from	NULL
murine	NULL
and	NULL
human	NULL
malignant	NULL
lymphocytes	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
purified	NULL
immune	NULL
immunoglobulin	NULL
G	NULL
was	NULL
covalently	NULL
linked	NULL
to	NULL
Sepharose	NULL
CL-4B	NULL
.	NULL

We	NULL
then	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
affinity	NULL
gel	NULL
to	NULL
recognize	NULL
cytosolic	NULL
[	NULL
°HJtriamcinolone	NULL
acetonide-receptor	NULL
complexes	NULL
from	NULL
the	NULL
corticoid-sensitive	NULL
(	NULL
CS	NULL
)	NULL
and	NULL
-resistant	NULL
strains	NULL
of	NULL
mouse	NULL
lymphoma	NULL
P1798	NULL
,	NULL
from	NULL
CS	NULL
lymphocytes	NULL
of	NULL
patients	NULL
with	NULL
chronic	NULL
lymphatic	NULL
leukemia	NULL
,	NULL
and	NULL
from	NULL
a	NULL
CS	NULL
clone	NULL
of	NULL
human	NULL
leukemic	NULL
lymphoblasts	NULL
in	NULL
tissue	NULL
culture	NULL
(	NULL
CH6	NULL
)	NULL
.	NULL

Mouse	NULL
thymus	NULL
was	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
from	NULL
normal	NULL
CS	NULL
lymphocytes	NULL
.	NULL

Whereas	NULL
the	NULL
immunoaffinity	NULL
column	NULL
retained	NULL
70	NULL
to	NULL
84	NULL
%	NULL
of	NULL
the	NULL
58-	NULL
to	NULL
62-A	NULL
(	NULL
Stokes	NULL
radius	NULL
)	NULL
[	NULL
PHItriamcino-lone	NULL
acetonide-receptor	NULL
complexes	NULL
characteristic	NULL
of	NULL
the	NULL
CS	NULL
mouse	NULL
and	NULL
human	NULL
lymphocytes	NULL
,	NULL
it	NULL
failed	NULL
to	NULL
recognize	NULL
the	NULL
27-to	NULL
28-A	NULL
(	NULL
Stokes	NULL
radius	NULL
)	NULL
glucocorticoid	NULL
receptor	NULL
present	NULL
in	NULL
corticoid-resistant	NULL
mouse	NULL
lymphoma	NULL
P1798	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
under	NULL
appropriate	NULL
experimental	NULL
conditions	NULL
,	NULL
it	NULL
was	NULL
possible	NULL
to	NULL
demonstrate	NULL
cross-reactivity	NULL
between	NULL
the	NULL
antiserum	NULL
against	NULL
rat	NULL
liver	NULL
glucocorticoid	NULL
receptor	NULL
and	NULL
the	NULL
58-	NULL
to	NULL
62-A	NULL
(	NULL
Stokes	NULL
radius	NULL
)	NULL
glucocorticoid	NULL
receptor	NULL
from	NULL
species	NULL
as	NULL
diverse	NULL
as	NULL
mouse	NULL
and	NULL
humans	NULL
.	NULL

INTRODUCTION	NULL
One	NULL
of	NULL
the	NULL
key	NULL
steps	NULL
in	NULL
the	NULL
action	NULL
of	NULL
glucocorticoids	NULL
and	NULL
other	NULL
steroids	NULL
on	NULL
target	NULL
tissues	NULL
appears	NULL
to	NULL
be	NULL
binding	NULL
of	NULL
the	NULL
hormone	NULL
to	NULL
specific	NULL
intracellular	NULL
receptor	NULL
proteins	NULL
(	NULL
1	NULL
,	NULL
8	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
physicochemical	NULL
properties	NULL
of	NULL
these	NULL
receptors	NULL
have	NULL
been	NULL
intensively	NULL
investigated	NULL
with	NULL
classic	NULL
techniques	NULL
of	NULL
protein	NULL
biochemistry	NULL
such	NULL
as	NULL
density	NULL
gradient	NULL
centrifugation	NULL
,	NULL
gel	NULL
filtra-tion	NULL
,	NULL
ion-exchange	NULL
chromatography	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
elec-trophoresis	NULL
,	NULL
and	NULL
isoelectric	NULL
focusing	NULL
(	NULL
15	NULL
,	NULL
22	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
purified	NULL
rat	NULL
liver	NULL
glucocorticoid	NULL
receptor	NULL
is	NULL
a	NULL
highly	NULL
asymmetrical	NULL
M.W	NULL
.	NULL

89,000	NULL
protein	NULL
with	NULL
a	NULL
R	NULL
,	NULL
°	NULL
of	NULL
60	NULL
A	NULL
,	NULL
a	NULL
sedimentation	NULL
coefficient	NULL
of	NULL
3.48	NULL
,	NULL
and	NULL
an	NULL
isoelectric	NULL
point	NULL
of	NULL
6.2	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Stevens	NULL
and	NULL
Stevens	NULL
(	NULL
17	NULL
)	NULL
found	NULL
that	NULL
the	NULL
physicochemical	NULL
properties	NULL
of	NULL
crude	NULL
glucocorticoid	NULL
receptors	NULL
from	NULL
CS	NULL
mouse	NULL
'	NULL
Supported	NULL
by	NULL
NIH	NULL
Grants	NULL
CA	NULL
14987	NULL
and	NULL
P	NULL
30	NULL
14194	NULL
,	NULL
by	NULL
American	NULL
Cancer	NULL
Society	NULL
Grant	NULL
BC-327	NULL
,	NULL
and	NULL
by	NULL
funds	NULL
from	NULL
the	NULL
Dworetz-Wolf	NULL
Foundation	NULL
for	NULL
Leukemia	NULL
Research	NULL
.	NULL

*	NULL
Scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
,	NULL
Inc.	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
R	NULL
,	NULL
,	NULL
Stokes	NULL
radius	NULL
;	NULL
CS	NULL
,	NULL
corticoid-sensitive	NULL
;	NULL
CR	NULL
,	NULL
corticoid-resistant	NULL
;	NULL
CLL	NULL
,	NULL
chronic	NULL
lymphatic	NULL
leukemia	NULL
;	NULL
TA	NULL
,	NULL
triamcinolone	NULL
aceto-nide	NULL
;	NULL
TES	NULL
,	NULL
tris	NULL
(	NULL
hydroxymethyl	NULL
)	NULL
methyl-2-aminoethane-sulfonic	NULL
acid	NULL
;	NULL
DTT	NULL
,	NULL
dithio-threitol	NULL
.	NULL

Received	NULL
June	NULL
16	NULL
,	NULL
1980	NULL
;	NULL
accepted	NULL
October	NULL
2	NULL
,	NULL
1980	NULL
.	NULL

134	NULL
P1798	NULL
tumor	NULL
lymphocytes	NULL
were	NULL
very	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
rat	NULL
liver	NULL
receptor	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
CR	NULL
strain	NULL
of	NULL
mouse	NULL
lymphoma	NULL
P1798	NULL
contained	NULL
receptors	NULL
that	NULL
were	NULL
much	NULL
smaller	NULL
(	NULL
M.W	NULL
.	NULL

40,000	NULL
;	NULL
R	NULL
,	NULL
,	NULL
27	NULL
to	NULL
28	NULL
A	NULL
;	NULL
*	NULL
sedimentation	NULL
coefficient	NULL
,	NULL
3.38	NULL
)	NULL
and	NULL
less	NULL
asymmetrical	NULL
than	NULL
the	NULL
receptors	NULL
present	NULL
in	NULL
the	NULL
CS	NULL
P1798	NULL
lymphocytes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
large	NULL
CS	NULL
P1798	NULL
glucocorticoid-receptor	NULL
complexes	NULL
bound	NULL
less	NULL
tightly	NULL
to	NULL
nuclei	NULL
(	NULL
20	NULL
)	NULL
and	NULL
DNA-cellulose	NULL
(	NULL
18	NULL
)	NULL
than	NULL
the	NULL
smaller	NULL
CR	NULL
complexes	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
their	NULL
extract-ability	NULL
with	NULL
monovalent	NULL
,	NULL
divalent	NULL
,	NULL
or	NULL
trivalent	NULL
cations	NULL
.	NULL

Govindan	NULL
(	NULL
4	NULL
)	NULL
and	NULL
Eisen	NULL
(	NULL
2	NULL
)	NULL
developed	NULL
specific	NULL
antisera	NULL
against	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

The	NULL
antibody	NULL
described	NULL
by	NULL
Eisen	NULL
did	NULL
not	NULL
cross-react	NULL
with	NULL
rat	NULL
serum	NULL
cortisol-binding	NULL
glob-ulin	NULL
,	NULL
rat	NULL
liver	NULL
glucocorticoid	NULL
binder	NULL
IB	NULL
(	NULL
10	NULL
)	NULL
,	NULL
or	NULL
rat	NULL
liver	NULL
estrogen-binding	NULL
protein	NULL
.	NULL

We	NULL
now	NULL
report	NULL
that	NULL
this	NULL
antibody	NULL
recognizes	NULL
the	NULL
59-	NULL
to	NULL
62-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
CS	NULL
mouse	NULL
lymphoma	NULL
P1798	NULL
glucocorticoid-receptor	NULL
complex	NULL
but	NULL
fails	NULL
to	NULL
recognize	NULL
the	NULL
27-	NULL
to	NULL
28-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
CR	NULL
P1798	NULL
receptor	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
antibody	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
58-	NULL
to	NULL
59-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
glucocorticoid	NULL
receptor	NULL
from	NULL
normal	NULL
mouse	NULL
thymus	NULL
as	NULL
well	NULL
as	NULL
the	NULL
59-	NULL
to	NULL
62-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
glucocorticoid	NULL
receptor	NULL
present	NULL
in	NULL
CS	NULL
human	NULL
acute	NULL
and	NULL
chronic	NULL
leukemic	NULL
lymphocytes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Preparation	NULL
of	NULL
Hormone-Receptor	NULL
Complexes	NULL
.	NULL

Cell	NULL
suspensions	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
CS	NULL
and	NULL
CR	NULL
strains	NULL
of	NULL
mouse	NULL
lymphoma	NULL
P1798	NULL
and	NULL
from	NULL
normal	NULL
female	NULL
BALB/c	NULL
mouse	NULL
thymus	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Lymphocytes	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
a	NULL
male	NULL
and	NULL
female	NULL
patient	NULL
with	NULL
untreated	NULL
CLL	NULL
as	NULL
reported	NULL
earlier	NULL
(	NULL
21	NULL
)	NULL
.	NULL

CH6	NULL
is	NULL
a	NULL
CS	NULL
clone	NULL
that	NULL
we	NULL
isolated	NULL
from	NULL
the	NULL
acute	NULL
lymphoblastic	NULL
leukemic	NULL
cell	NULL
line	NULL
,	NULL
CCRF-CEM	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Bethesda	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

,	NULL
by	NULL
the	NULL
limiting	NULL
dilution	NULL
technique	NULL
.	NULL

Its	NULL
growth	NULL
is	NULL
inhibited	NULL
by	NULL
0.1	NULL
to	NULL
1	NULL
um	NULL
TA	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
resembles	NULL
clone	NULL
C7	NULL
of	NULL
Norman	NULL
and	NULL
Thompson	NULL
(	NULL
11	NULL
)	NULL
and	NULL
Harmon	NULL
et	NULL
al	NULL
.	NULL

(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
properties	NULL
of	NULL
CHG	NULL
will	NULL
be	NULL
described	NULL
in	NULL
detail	NULL
elsewhere	NULL
.	NULL

Cells	NULL
were	NULL
homogenized	NULL
in	NULL
a	NULL
4°	NULL
cold	NULL
room	NULL
with	NULL
10	NULL
strokes	NULL
of	NULL
a	NULL
motor-driven	NULL
glass-Teflon	NULL
Potter-Elvehjem	NULL
homogenizer	NULL
in	NULL
3	NULL
(	NULL
thymus	NULL
,	NULL
CLL	NULL
)	NULL
or	NULL
5	NULL
to	NULL
6	NULL
(	NULL
P1798	NULL
,	NULL
CHG	NULL
)	NULL
volumes	NULL
of	NULL
10	NULL
mm	NULL
TES:4	NULL
mm	NULL
EDTA	NULL
:	NULL
10	NULL
mm	NULL
DTT	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
at	NULL
4°	NULL
,	NULL
containing	NULL
50	NULL
nm	NULL
(	NULL
°HJTA	NULL
(	NULL
31.3	NULL
Ci/mmol	NULL
;	NULL
New	NULL
England	NULL
Nuclear	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

alone	NULL
or	NULL
50	NULL
nm	NULL
[	NULL
°HJTA	NULL
pilus	NULL
5	NULL
um	NULL
nonradioactive	NULL
TA	NULL
.	NULL

The	NULL
homogenizer	NULL
was	NULL
constantly	NULL
immersed	NULL
in	NULL
an	NULL
ice	NULL
water	NULL
bath	NULL
,	NULL
and	NULL
10-sec	NULL
intervals	NULL
were	NULL
allowed	NULL
between	NULL
strokes	NULL
to	NULL
ensure	NULL
rigorous	NULL
temperature	NULL
control	NULL
.	NULL

Cytosol	NULL
was	NULL
obtained	NULL
by	NULL
spinning	NULL
the	NULL
*	NULL
The	NULL
previously	NULL
reported	NULL
value	NULL
of	NULL
29	NULL
to	NULL
30	NULL
A	NULL
was	NULL
calculated	NULL
by	NULL
assigning	NULL
a	NULL
R	NULL
,	NULL
of	NULL
30.5	NULL
A	NULL
to	NULL
the	NULL
ovalbumin	NULL
standard	NULL
.	NULL

However	NULL
,	NULL
Sherman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
16	NULL
)	NULL
reported	NULL
recently	NULL
that	NULL
28.6	NULL
A	NULL
was	NULL
a	NULL
more	NULL
accurate	NULL
value	NULL
for	NULL
ovalbumin	NULL
,	NULL
and	NULL
we	NULL
have	NULL
revised	NULL
the	NULL
R	NULL
,	NULL
of	NULL
the	NULL
CR	NULL
P1798	NULL
glucocorticoid	NULL
receptor	NULL
accordingly	NULL
.	NULL

CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

41	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1981	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

homogenate	NULL
for	NULL
15	NULL
min	NULL
at	NULL
27,000	NULL
x	NULL
g	NULL
and	NULL
recentrifuging	NULL
the	NULL
27,000	NULL
x	NULL
g	NULL
supernatant	NULL
for	NULL
30	NULL
min	NULL
at	NULL
100,000	NULL
x	NULL
g.	NULL
After	NULL
3	NULL
hr	NULL
of	NULL
incubation	NULL
(	NULL
from	NULL
the	NULL
time	NULL
of	NULL
homogenization	NULL
)	NULL
at	NULL
4°	NULL
,	NULL
free	NULL
steroid	NULL
was	NULL
adsorbed	NULL
with	NULL
activated	NULL
charcoal	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Specific	NULL
binding	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
difference	NULL
,	NULL
after	NULL
charcoal	NULL
treat-ment	NULL
,	NULL
between	NULL
dpm/mg	NULL
protein	NULL
in	NULL
cytosol	NULL
incubated	NULL
with	NULL
[	NULL
°HJTA	NULL
alone	NULL
and	NULL
dpm/mg	NULL
protein	NULL
in	NULL
cytosol	NULL
incubated	NULL
with	NULL
radioactive	NULL
plus	NULL
nonradioactive	NULL
steroid	NULL
.	NULL

Nonspecific	NULL
binding	NULL
was	NULL
2	NULL
to	NULL
10	NULL
%	NULL
of	NULL
the	NULL
total	NULL
binding	NULL
level	NULL
in	NULL
the	NULL
various	NULL
cytosols	NULL
.	NULL

Therefore	NULL
,	NULL
cytosols	NULL
incubated	NULL
with	NULL
excess	NULL
nonradioactive	NULL
steroid	NULL
were	NULL
not	NULL
further	NULL
analyzed	NULL
.	NULL

Protein	NULL
was	NULL
measured	NULL
with	NULL
Coomassie	NULL
blue	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Sedmak	NULL
and	NULL
Grossberg	NULL
(	NULL
14	NULL
)	NULL
.	NULL

DTT	NULL
does	NULL
not	NULL
interfere	NULL
with	NULL
this	NULL
assay	NULL
.	NULL

Immunoaffinity	NULL
Chromatography	NULL
.	NULL

Antibody	NULL
against	NULL
purified	NULL
rat	NULL
liver	NULL
[	NULL
°HJTA-receptor	NULL
complex	NULL
was	NULL
raised	NULL
,	NULL
purified	NULL
,	NULL
and	NULL
coupled	NULL
to	NULL
Sepharose	NULL
CL-4B	NULL
(	NULL
Pharmacia	NULL
Fine	NULL
Chemicals	NULL
,	NULL
Inc.	NULL
,	NULL
Piscataway	NULL
,	NULL
N	NULL
.	NULL

J	NULL
.	NULL
)	NULL

as	NULL
described	NULL
previously	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
immune	NULL
1gG-Sepharose	NULL
was	NULL
equilibrated	NULL
with	NULL
10	NULL
mm	NULL
TES:4	NULL
mm	NULL
EDTA	NULL
:	NULL
0.5	NULL
m	NULL
NaCl	NULL
:	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
and	NULL
packed	NULL
into	NULL
a	NULL
1-	NULL
x	NULL
4-cm	NULL
column	NULL
.	NULL

A	NULL
column	NULL
of	NULL
identical	NULL
dimensions	NULL
was	NULL
prepared	NULL
with	NULL
Sepharose	NULL
CL-4B	NULL
to	NULL
which	NULL
IgG	NULL
from	NULL
a	NULL
nonimmunized	NULL
rabbit	NULL
had	NULL
been	NULL
covalently	NULL
attached	NULL
.	NULL

Immediately	NULL
before	NULL
use	NULL
,	NULL
the	NULL
columns	NULL
were	NULL
equilibrated	NULL
with	NULL
10	NULL
mm	NULL
TES:4	NULL
mm	NULL
EDTA	NULL
:	NULL
O.5	NULL
m	NULL
NaCI:10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
plus	NULL
0.5	NULL
mm	NULL
DTT	NULL
.	NULL

Cytosols	NULL
were	NULL
adjusted	NULL
to	NULL
0.5	NULL
m	NULL
NaCl	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
0.25	NULL
volume	NULL
of	NULL
the	NULL
same	NULL
buffer	NULL
containing	NULL
2.5	NULL
m	NULL
NaCl	NULL
.	NULL

Samples	NULL
(	NULL
0.5	NULL
ml	NULL
)	NULL
were	NULL
applied	NULL
to	NULL
the	NULL
column	NULL
by	NULL
gravity	NULL
flow	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
7	NULL
to	NULL
10	NULL
ml	NULL
of	NULL
the	NULL
equilibrating	NULL
buffer	NULL
and	NULL
then	NULL
eluted	NULL
with	NULL
10	NULL
ml	NULL
of	NULL
0.1	NULL
m	NULL
acetic	NULL
acid	NULL
.	NULL

This	NULL
procedure	NULL
,	NULL
which	NULL
removes	NULL
all	NULL
the	NULL
adsorbed	NULL
cytosolic	NULL
proteins	NULL
and	NULL
radioactivity	NULL
from	NULL
the	NULL
column	NULL
,	NULL
also	NULL
denatures	NULL
the	NULL
receptor	NULL
and	NULL
causes	NULL
complete	NULL
dissociation	NULL
of	NULL
the	NULL
radioactive	NULL
ligand	NULL
.	NULL

The	NULL
column	NULL
was	NULL
returned	NULL
to	NULL
pH	NULL
7.5	NULL
by	NULL
washing	NULL
with	NULL
10	NULL
mm	NULL
TES:4	NULL
mm	NULL
EDTA	NULL
:	NULL
O.5	NULL
m	NULL
NaC	NULL
)	NULL
:	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
containing	NULL
0.1	NULL
m	NULL
TES	NULL
and	NULL
then	NULL
equilibrated	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
containing	NULL
the	NULL
usual	NULL
concentration	NULL
(	NULL
10	NULL
mm	NULL
)	NULL
of	NULL
TES	NULL
.	NULL

Two	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
each	NULL
cytosol	NULL
.	NULL

In	NULL
one	NULL
experiment	NULL
,	NULL
portions	NULL
of	NULL
the	NULL
same	NULL
cytosol	NULL
were	NULL
run	NULL
in	NULL
parallel	NULL
on	NULL
the	NULL
``	NULL
immune	NULL
``	NULL
and	NULL
'	NULL
``	NULL
nonimmune	NULL
``	NULL
column	NULL
to	NULL
correct	NULL
for	NULL
small	NULL
amounts	NULL
of	NULL
[	NULL
°HJTA	NULL
bound	NULL
to	NULL
the	NULL
latter	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
hormone-receptor	NULL
complexes	NULL
were	NULL
not	NULL
cleaved	NULL
during	NULL
preparation	NULL
of	NULL
the	NULL
cytosol	NULL
,	NULL
an	NULL
additional	NULL
portion	NULL
in	NULL
each	NULL
experiment	NULL
was	NULL
analyzed	NULL
by	NULL
agarose	NULL
get	NULL
filtration	NULL
[	NULL
Bio-Gel	NULL
A-1.5m	NULL
(	NULL
100	NULL
to	NULL
200	NULL
mesh	NULL
)	NULL
or	NULL
Bio-Gel	NULL
A-0.5m	NULL
(	NULL
100	NULL
to	NULL
200	NULL
mesh	NULL
)	NULL
;	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Rockville	NULL
Centre	NULL
,	NULL
N	NULL
.	NULL

Y	NULL
.	NULL
]	NULL

,	NULL
using	NULL
previously	NULL
described	NULL
methods	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
pooled	NULL
drop-through	NULL
fractions	NULL
from	NULL
the	NULL
nonimmune	NULL
column	NULL
were	NULL
also	NULL
subjected	NULL
to	NULL
agarose	NULL
gel	NULL
filtration	NULL
.	NULL

Radioactivity	NULL
was	NULL
counted	NULL
as	NULL
described	NULL
previously	NULL
with	NULL
20	NULL
to	NULL
33	NULL
%	NULL
efficiency	NULL
(	NULL
17	NULL
)	NULL
.	NULL

RESULTS	NULL
Immunocaffinity	NULL
Chromatography	NULL
of	NULL
Mouse	NULL
Lymphoid	NULL
Glucocorticoid-Receptor	NULL
Complexes	NULL
.	NULL

Chart	NULL
1	NULL
shows	NULL
that	NULL
84	NULL
%	NULL
of	NULL
CS	NULL
P1798	NULL
[	NULL
PHJTA-receptor	NULL
complexes	NULL
were	NULL
retained	NULL
by	NULL
immune	NULL
IgG-Sepharose	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
only	NULL
1	NULL
%	NULL
of	NULL
[	NULL
°HJTA	NULL
complexes	NULL
in	NULL
another	NULL
portion	NULL
of	NULL
the	NULL
same	NULL
cytosol	NULL
were	NULL
adsorbed	NULL
to	NULL
the	NULL
nonimmune	NULL
column	NULL
.	NULL

Gel	NULL
filtration	NULL
on	NULL
Bio-Gel	NULL
A-1.5m	NULL
showed	NULL
that	NULL
85	NULL
%	NULL
of	NULL
the	NULL
radioactivity	NULL
in	NULL
the	NULL
pooled	NULL
drop-through	NULL
fractions	NULL
of	NULL
the	NULL
nonimmune	NULL
column	NULL
was	NULL
present	NULL
as	NULL
the	NULL
typical	NULL
59-to	NULL
62-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
CS	NULL
P1798	NULL
[	NULL
°HJTA-receptor	NULL
complex	NULL
.	NULL

Therefore	NULL
,	NULL
JANUARY	NULL
1981	NULL
Immunochemical	NULL
Studies	NULL
of	NULL
Glucocorticoid	NULL
Receptors	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
nonimmune	NULL
gel	NULL
to	NULL
retain	NULL
bound	NULL
[	NULL
°HIJTA	NULL
was	NULL
not	NULL
due	NULL
to	NULL
dissociation	NULL
or	NULL
degradation	NULL
of	NULL
hormone-receptor	NULL
complexes	NULL
as	NULL
they	NULL
passed	NULL
through	NULL
the	NULL
column	NULL
.	NULL

This	NULL
experiment	NULL
also	NULL
rules	NULL
out	NULL
nonspecific	NULL
recognition	NULL
of	NULL
CS	NULL
P1798	NULL
BH	NULL
}	NULL
TA	NULL
complexes	NULL
by	NULL
normal	NULL
rabbit	NULL
IgG	NULL
.	NULL

Chart	NULL
2	NULL
illustrates	NULL
the	NULL
striking	NULL
ability	NULL
of	NULL
the	NULL
immune	NULL
IgG-Sepharose	NULL
column	NULL
to	NULL
distinguish	NULL
between	NULL
59-	NULL
to	NULL
62-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
CS	NULL
P1798	NULL
and	NULL
27-	NULL
to	NULL
28-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
CR	NULL
P1798	NULL
[	NULL
°H	NULL
]	NULL
JTA-receptor	NULL
complexes	NULL
.	NULL

Whereas	NULL
78	NULL
%	NULL
of	NULL
CS	NULL
complexes	NULL
were	NULL
adsorbed	NULL
onto	NULL
the	NULL
immune	NULL
column	NULL
,	NULL
only	NULL
1	NULL
%	NULL
of	NULL
CR	NULL
complexes	NULL
were	NULL
retained	NULL
by	NULL
the	NULL
affinity	NULL
gel	NULL
.	NULL

Over	NULL
85	NULL
%	NULL
of	NULL
the	NULL
nonretained	NULL
radioactivity	NULL
in	NULL
CR	NULL
cytosol	NULL
was	NULL
recovered	NULL
as	NULL
the	NULL
27-	NULL
to	NULL
28-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
complex	NULL
in	NULL
the	NULL
pooled	NULL
drop-through	NULL
fractions	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
failure	NULL
of	NULL
immune	NULL
1IgG-Sepharose	NULL
to	NULL
recognize	NULL
CR	NULL
P1798	NULL
{	NULL
°HJTA-receptor	NULL
complexes	NULL
was	NULL
not	NULL
attributable	NULL
to	NULL
dissociation	NULL
of	NULL
the	NULL
ligand	NULL
or	NULL
cleavage	NULL
of	NULL
the	NULL
receptor	NULL
on	NULL
the	NULL
column	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
immune	NULL
gel	NULL
could	NULL
recognize	NULL
glucocorticoid	NULL
receptor	NULL
from	NULL
normal	NULL
lymphocytes	NULL
,	NULL
we	NULL
prepared	NULL
[	NULL
°H	NULL
]	NULL
JTA-labeled	NULL
cytosol	NULL
from	NULL
mouse	NULL
thymocytes	NULL
and	NULL
passed	NULL
it	NULL
through	NULL
the	NULL
immune	NULL
and	NULL
nonimmune	NULL
columns	NULL
.	NULL

We	NULL
verified	NULL
,	NULL
by	NULL
gel	NULL
filtration	NULL
on	NULL
Bio-Gel	NULL
A-1.5m	NULL
,	NULL
that	NULL
80	NULL
%	NULL
of	NULL
bound	NULL
[	NULL
°HJTA	NULL
in	NULL
the	NULL
cytosol	NULL
prior	NULL
to	NULL
immunoaffinity	NULL
chromatography	NULL
was	NULL
in	NULL
the	NULL
form	NULL
of	NULL
a	NULL
58-	NULL
to	NULL
59-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
complex	NULL
(	NULL
range	NULL
of	NULL
2	NULL
experiments	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
20	NULL
%	NULL
eluted	NULL
as	NULL
a	NULL
26-A	NULL
peak	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
68	NULL
to	NULL
72	NULL
%	NULL
of	NULL
input	NULL
[	NULL
°HJTA	NULL
complexes	NULL
were	NULL
retained	NULL
by	NULL
the	NULL
immune	NULL
column	NULL
,	NULL
compared	NULL
to	NULL
only	NULL
1	NULL
%	NULL
by	NULL
the	NULL
nonimmune	NULL
column	NULL
.	NULL

The	NULL
Bio-Gel	NULL
A-1.5m	NULL
elution	NULL
profile	NULL
of	NULL
the	NULL
pooled	NULL
drop-through	NULL
fractions	NULL
from	NULL
the	NULL
nonimmune	NULL
column	NULL
was	NULL
practically	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
cytosol	NULL
which	NULL
had	NULL
not	NULL
been	NULL
subjected	NULL
to	NULL
immunoaffinity	NULL
chromatography	NULL
.	NULL

Immunoaffinity	NULL
Chromatography	NULL
of	NULL
Human	NULL
Lymphoid	NULL
Glucocorticoid-Receptor	NULL
Complexes	NULL
.	NULL

Table	NULL
1	NULL
also	NULL
shows	NULL
that	NULL
antibody	NULL
raised	NULL
against	NULL
rat	NULL
liver	NULL
glucocorticoid	NULL
receptor	NULL
recognized	NULL
the	NULL
59-	NULL
to	NULL
61-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
[	NULL
PH	NULL
]	NULL
JTA-receptor	NULL
complex	NULL
present	NULL
in	NULL
CS	NULL
human	NULL
leukemic	NULL
lymphocytes	NULL
.	NULL

Thus	NULL
,	NULL
immune	NULL
IgG-Seph-	NULL
n	NULL
,	NULL
,	NULL
Nonimmune	NULL
__.lmmune	NULL
[	NULL
34	NULL
]	NULL
TA	NULL
10	NULL
%	NULL
4	NULL
x	NULL
apm	NULL
/froction	NULL
0	NULL
5	NULL
10	NULL
Fraction	NULL
Chart	NULL
1	NULL
.	NULL

Chromatography	NULL
of	NULL
[	NULL
°HJTA-labeled	NULL
cytosol	NULL
from	NULL
CS	NULL
P1798	NULL
tumor	NULL
lymphocytes	NULL
on	NULL
``	NULL
immune	NULL
``	NULL
(	NULL
@	NULL
)	NULL
and	NULL
``	NULL
nonimmune	NULL
``	NULL
(	NULL
O	NULL
)	NULL
igG-Sepharose	NULL
CL-4B	NULL
.	NULL

Arrow	NULL
,	NULL
start	NULL
of	NULL
elution	NULL
with	NULL
0.1	NULL
m	NULL
acetic	NULL
acid	NULL
.	NULL

135	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1981	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

J.	NULL
Stevens	NULL
et	NULL
al	NULL
.	NULL

°f	NULL
o	NULL
I	NULL
_	NULL
,	NULL
.CcsS	NULL
PI17	NULL
?	NULL

98	NULL
_.CR	NULL
Pi7	NULL
?	NULL

98	NULL
c	NULL
6	NULL
[	NULL
-o	NULL
GC	NULL
P	NULL
~	NULL
€	NULL
Q	NULL
UO	NULL
x	NULL
4	NULL
|-Kj	NULL
o	NULL
4	NULL
|-C	NULL
Cu	NULL
2	NULL
.	NULL

O	NULL
5	NULL
10	NULL
15	NULL
Fraction	NULL
Chart	NULL
2	NULL
.	NULL

Chromatography	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
TA-labeted	NULL
cytosol	NULL
from	NULL
CS	NULL
(	NULL
@	NULL
)	NULL
and	NULL
CR	NULL
P1798	NULL
(	NULL
0	NULL
)	NULL
tumor	NULL
lymphocytes	NULL
on	NULL
``	NULL
immune®	NULL
IgG-Sepharose	NULL
CL-4B	NULL
.	NULL

Arrow	NULL
,	NULL
start	NULL
of	NULL
elution	NULL
with	NULL
0.1	NULL
m	NULL
acetic	NULL
acid	NULL
.	NULL

arose	NULL
cross-reacted	NULL
with	NULL
67	NULL
to	NULL
69	NULL
%	NULL
of	NULL
[	NULL
°HJTA	NULL
complexes	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
CHG	NULL
lymphocytes	NULL
,	NULL
a	NULL
CS	NULL
clone	NULL
of	NULL
human	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
cells	NULL
in	NULL
tissue	NULL
culture	NULL
,	NULL
and	NULL
with	NULL
70	NULL
%	NULL
of	NULL
cytosolic	NULL
[	NULL
°HJTA	NULL
complexes	NULL
from	NULL
freshly	NULL
isolated	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
of	NULL
2	NULL
patients	NULL
with	NULL
CLL	NULL
.	NULL

Lymphocytes	NULL
from	NULL
these	NULL
2	NULL
patients	NULL
were	NULL
glucocorticoid	NULL
responsive	NULL
as	NULL
judged	NULL
by	NULL
TA	NULL
suppression	NULL
of	NULL
uridine	NULL
utilization	NULL
in	NULL
vitro	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
all	NULL
in-stances	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
pooled	NULL
drop-through	NULL
fractions	NULL
of	NULL
the	NULL
nonimmune	NULL
column	NULL
by	NULL
gel	NULL
filtration	NULL
on	NULL
Bio-Gel	NULL
A-1.5m	NULL
.	NULL

For	NULL
CH6	NULL
,	NULL
64	NULL
%	NULL
of	NULL
the	NULL
radioactivity	NULL
was	NULL
in	NULL
the	NULL
form	NULL
of	NULL
a	NULL
58-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
complex	NULL
and	NULL
the	NULL
remainder	NULL
was	NULL
free	NULL
[	NULL
°H	NULL
]	NULL
JTA	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
CLL	NULL
cytosol	NULL
,	NULL
88	NULL
%	NULL
of	NULL
the	NULL
[	NULL
°HIJTA	NULL
was	NULL
present	NULL
in	NULL
the	NULL
61-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
peak	NULL
.	NULL

The	NULL
remaining	NULL
radioactivity	NULL
was	NULL
free	NULL
steroid	NULL
.	NULL

None	NULL
of	NULL
the	NULL
human	NULL
cytosols	NULL
contained	NULL
appreciable	NULL
amounts	NULL
of	NULL
27-	NULL
to	NULL
28-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
material	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
the	NULL
greater	NULL
instability	NULL
of	NULL
CH6	NULL
[	NULL
PHIJTA-receptor	NULL
complexes	NULL
remains	NULL
the	NULL
subject	NULL
for	NULL
future	NULL
investiga-tion	NULL
.	NULL

DISCUSSION	NULL
The	NULL
antiserum	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
was	NULL
produced	NULL
in	NULL
a	NULL
rabbit	NULL
that	NULL
had	NULL
been	NULL
immunized	NULL
with	NULL
a	NULL
highly	NULL
purified	NULL
preparation	NULL
of	NULL
rat	NULL
liver	NULL
[	NULL
°H	NULL
]	NULL
JTA-receptor	NULL
complex	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
antigen	NULL
was	NULL
prepared	NULL
by	NULL
the	NULL
2-stage	NULL
DNA-cellulose	NULL
chromatography	NULL
procedure	NULL
of	NULL
Eisen	NULL
and	NULL
Glinsmann	NULL
(	NULL
3	NULL
)	NULL
and	NULL
was	NULL
approximately	NULL
30	NULL
%	NULL
pure	NULL
.	NULL

Although	NULL
this	NULL
antiserum	NULL
did	NULL
not	NULL
contain	NULL
precipitating	NULL
antibodies	NULL
,	NULL
IgG	NULL
from	NULL
the	NULL
antiserum	NULL
formed	NULL
a	NULL
soluble	NULL
complex	NULL
with	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
as	NULL
determined	NULL
by	NULL
gel	NULL
permea-	NULL
136	NULL
Table	NULL
1	NULL
Summary	NULL
of	NULL
immunoaffinity	NULL
chromatography	NULL
of	NULL
mouse	NULL
and	NULL
human	NULL
lymphoid	NULL
glucocorticoid	NULL
receptor	NULL
complexes	NULL
The	NULL
amount	NULL
of	NULL
protein	NULL
applied	NULL
varied	NULL
from	NULL
1.54	NULL
to	NULL
3.32	NULL
mg	NULL
.	NULL

Input	NULL
dpm	NULL
varied	NULL
from	NULL
55,000	NULL
to	NULL
156,000	NULL
.	NULL

%	NULL
of	NULL
input	NULL
dpm	NULL
adsorbed	NULL
Cytosol	NULL
Immune	NULL
gel	NULL
Nonimmune	NULL
gel	NULL
CS	NULL
P1798	NULL
1	NULL
78	NULL
ND*	NULL
2	NULL
84	NULL
1	NULL
CR	NULL
P1798	NULL
1	NULL
2.4	NULL
ND	NULL
2	NULL
1.0	NULL
ND	NULL
Mouse	NULL
thymus	NULL
1	NULL
72	NULL
ND	NULL
2	NULL
68	NULL
0.8	NULL
CHG	NULL
1	NULL
67	NULL
ND	NULL
2	NULL
69	NULL
1	NULL
CLL	NULL
J.	NULL
M.	NULL
70	NULL
1	NULL
L.	NULL
C.	NULL
70	NULL
1	NULL
``	NULL
ND	NULL
,	NULL
not	NULL
done	NULL
.	NULL

tion	NULL
chromatography	NULL
.	NULL

These	NULL
complexes	NULL
can	NULL
be	NULL
precipitated	NULL
by	NULL
staphylococcal	NULL
protein	NULL
A	NULL
(	NULL
Pansorbin	NULL
;	NULL
Calbiochem-Behring	NULL
Corp.	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
and	NULL
by	NULL
goat	NULL
antibody	NULL
to	NULL
rabbit	NULL
IgG	NULL
.	NULL

Since	NULL
only	NULL
limited	NULL
quantities	NULL
of	NULL
high-titer	NULL
antiserum	NULL
were	NULL
obtained	NULL
from	NULL
this	NULL
rabbit	NULL
,	NULL
IgG	NULL
was	NULL
purified	NULL
and	NULL
covalently	NULL
linked	NULL
to	NULL
Sepharose	NULL
CL-4B	NULL
.	NULL

The	NULL
immobilized	NULL
antibody	NULL
can	NULL
be	NULL
regenerated	NULL
and	NULL
used	NULL
for	NULL
multiple	NULL
analyses	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
antigen	NULL
was	NULL
glucocorticoid	NULL
receptor	NULL
from	NULL
rat	NULL
liver	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
immunoaffinity	NULL
gel	NULL
could	NULL
be	NULL
used	NULL
to	NULL
analyze	NULL
glucocorticoid	NULL
receptors	NULL
from	NULL
other	NULL
species	NULL
.	NULL

In	NULL
the	NULL
initial	NULL
studies	NULL
(	NULL
2	NULL
)	NULL
,	NULL
mouse	NULL
liver	NULL
receptor	NULL
was	NULL
found	NULL
to	NULL
cross-react	NULL
with	NULL
this	NULL
antiserum	NULL
.	NULL

However	NULL
,	NULL
only	NULL
10	NULL
to	NULL
20	NULL
%	NULL
of	NULL
an	NULL
input	NULL
``	NULL
load	NULL
``	NULL
``	NULL
of	NULL
200	NULL
pmol	NULL
of	NULL
(	NULL
R	NULL
,	NULL
)	NULL
mouse	NULL
liver	NULL
[	NULL
°HJTA-receptor	NULL
complexes	NULL
was	NULL
adsorbed	NULL
by	NULL
a	NULL
column	NULL
that	NULL
retained	NULL
over	NULL
200	NULL
pmol	NULL
of	NULL
60-A	NULL
rat	NULL
liver	NULL
glucocorticoid	NULL
receptors	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
the	NULL
cross-reactivity	NULL
was	NULL
incom-plete	NULL
.	NULL

In	NULL
the	NULL
current	NULL
experiments	NULL
,	NULL
we	NULL
have	NULL
used	NULL
small	NULL
input	NULL
loads	NULL
of	NULL
1	NULL
to	NULL
2	NULL
pmol	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
70	NULL
%	NULL
of	NULL
[	NULL
°HJTA-receptor	NULL
complexes	NULL
from	NULL
normal	NULL
mouse	NULL
thymus	NULL
and	NULL
from	NULL
human	NULL
leukemic	NULL
lymphocytes	NULL
and	NULL
80	NULL
%	NULL
of	NULL
[	NULL
°HJTA-receptor	NULL
complexes	NULL
from	NULL
CS	NULL
mouse	NULL
lymphoma	NULL
P1798	NULL
cells	NULL
were	NULL
adsorbed	NULL
by	NULL
the	NULL
immunoaffinity	NULL
column	NULL
.	NULL

When	NULL
more	NULL
antibody	NULL
is	NULL
produced	NULL
,	NULL
it	NULL
will	NULL
be	NULL
important	NULL
to	NULL
define	NULL
parameters	NULL
such	NULL
as	NULL
antibody	NULL
affinity	NULL
and	NULL
heterogeneity	NULL
using	NULL
standard	NULL
equilibrium	NULL
techniques	NULL
for	NULL
quantitating	NULL
cross-reactivity	NULL
.	NULL

It	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
the	NULL
58-	NULL
to	NULL
62-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
hormone-receptor	NULL
complexes	NULL
that	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
immune	NULL
column	NULL
belong	NULL
to	NULL
a	NULL
subpopulation	NULL
with	NULL
different	NULL
im-munochemica	NULL
!	NULL

properties	NULL
from	NULL
the	NULL
majority	NULL
of	NULL
[	NULL
°HJTA	NULL
complexes	NULL
in	NULL
a	NULL
given	NULL
cytosol	NULL
preparation	NULL
or	NULL
failure	NULL
of	NULL
all	NULL
the	NULL
complexes	NULL
to	NULL
bind	NULL
simply	NULL
reflects	NULL
an	NULL
equilibrium	NULL
process	NULL
.	NULL

Eisen	NULL
(	NULL
2	NULL
)	NULL
had	NULL
observed	NULL
previously	NULL
that	NULL
22	NULL
%	NULL
of	NULL
[	NULL
°HJTA	NULL
complexes	NULL
in	NULL
rat	NULL
liver	NULL
cytosol	NULL
were	NULL
not	NULL
adsorbed	NULL
by	NULL
immune	NULL
IgG-Sepharose	NULL
prepared	NULL
with	NULL
IgG	NULL
from	NULL
the	NULL
same	NULL
batch	NULL
of	NULL
antiserum	NULL
used	NULL
in	NULL
the	NULL
present	NULL
experiments	NULL
.	NULL

Govindan	NULL
(	NULL
4	NULL
)	NULL
reported	NULL
72	NULL
%	NULL
retention	NULL
of	NULL
rat	NULL
liver	NULL
dexamethasone-binding	NULL
activity	NULL
on	NULL
immune	NULL
1gG-Sepharose	NULL
prepared	NULL
with	NULL
rabbit	NULL
antibody	NULL
against	NULL
purified	NULL
rat	NULL
liver	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

41	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1981	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

Greene	NULL
et	NULL
al	NULL
.	NULL

(	NULL
5	NULL
)	NULL
demonstrated	NULL
immunochemical	NULL
similarity	NULL
among	NULL
estrogen	NULL
receptors	NULL
from	NULL
8	NULL
mammalian	NULL
species	NULL
,	NULL
including	NULL
those	NULL
isolated	NULL
from	NULL
human	NULL
tissue	NULL
.	NULL

These	NULL
authors	NULL
also	NULL
made	NULL
the	NULL
interesting	NULL
observation	NULL
that	NULL
antibodies	NULL
produced	NULL
by	NULL
a	NULL
Lewis	NULL
rat	NULL
reacted	NULL
only	NULL
with	NULL
calf	NULL
uterus	NULL
estrogen	NULL
receptor	NULL
,	NULL
the	NULL
protein	NULL
against	NULL
which	NULL
they	NULL
were	NULL
raised	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
rat	NULL
liver	NULL
glucocorticoid	NULL
receptor	NULL
and	NULL
cytosolic	NULL
lymphoid	NULL
[	NULL
°H	NULL
]	NULL
JTA-receptor	NULL
complexes	NULL
from	NULL
species	NULL
as	NULL
diverse	NULL
as	NULL
mouse	NULL
and	NULL
humans	NULL
may	NULL
share	NULL
antigenic	NULL
determinants	NULL
.	NULL

The	NULL
antibody	NULL
used	NULL
in	NULL
the	NULL
work	NULL
described	NULL
here	NULL
was	NULL
raised	NULL
against	NULL
60-A	NULL
[	NULL
°HJTA-receptor	NULL
complexes	NULL
(	NULL
2	NULL
)	NULL
.	NULL

All	NULL
the	NULL
[	NULL
°HITA	NULL
complexes	NULL
it	NULL
recognized	NULL
had	NULL
a	NULL
R	NULL
,	NULL
of	NULL
58	NULL
to	NULL
62	NULL
A	NULL
.	NULL

Its	NULL
failure	NULL
to	NULL
cross-react	NULL
with	NULL
the	NULL
27-	NULL
to	NULL
28-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
[	NULL
PHJTA	NULL
complex	NULL
present	NULL
in	NULL
CR	NULL
P1798	NULL
mouse	NULL
tumor	NULL
lymphocytes	NULL
suggests	NULL
that	NULL
the	NULL
antibodies	NULL
recognized	NULL
the	NULL
62	NULL
-	NULL
27	NULL
A	NULL
region	NULL
of	NULL
the	NULL
receptor	NULL
molecule	NULL
,	NULL
/.e	NULL
.	NULL

,	NULL
that	NULL
portion	NULL
of	NULL
the	NULL
59-	NULL
to	NULL
62-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
glucocorticoid	NULL
receptor	NULL
from	NULL
CS	NULL
P1798	NULL
lymphocytes	NULL
that	NULL
can	NULL
be	NULL
selectively	NULL
digested	NULL
by	NULL
chymotrypsin	NULL
under	NULL
appropriate	NULL
in	NULL
vitro	NULL
conditions	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Another	NULL
explanation	NULL
is	NULL
that	NULL
the	NULL
27-	NULL
to	NULL
28-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
fragment	NULL
obtained	NULL
by	NULL
chymotrypsin	NULL
digestion	NULL
of	NULL
the	NULL
59-	NULL
to	NULL
62-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
receptor	NULL
is	NULL
immunochemically	NULL
different	NULL
from	NULL
the	NULL
27-	NULL
to	NULL
28-A	NULL
(	NULL
R	NULL
,	NULL
)	NULL
glucocorticoid	NULL
receptor	NULL
in	NULL
undigested	NULL
CR	NULL
P1798	NULL
lympho-cyte	NULL
cytosol	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
both	NULL
regions	NULL
of	NULL
the	NULL
receptor	NULL
molecule	NULL
are	NULL
required	NULL
for	NULL
antigenic	NULL
recognition	NULL
.	NULL

However	NULL
,	NULL
the	NULL
antibody	NULL
preparation	NULL
described	NULL
by	NULL
Govindan	NULL
reacted	NULL
not	NULL
only	NULL
with	NULL
intact	NULL
(	NULL
M.W	NULL
.	NULL

90,000	NULL
)	NULL
rat	NULL
liver	NULL
glucocorticoid-receptor	NULL
complexes	NULL
but	NULL
also	NULL
with	NULL
a	NULL
M.W	NULL
.	NULL

45,000	NULL
cleavage	NULL
product	NULL
(	NULL
4	NULL
)	NULL
.	NULL

So	NULL
far	NULL
,	NULL
we	NULL
have	NULL
been	NULL
unsuccessful	NULL
in	NULL
eluting	NULL
native	NULL
[	NULL
°HJTA-receptor	NULL
complexes	NULL
from	NULL
the	NULL
immunoaffinity	NULL
column	NULL
.	NULL

Once	NULL
this	NULL
problem	NULL
is	NULL
resolved	NULL
,	NULL
immunoaffinity	NULL
chromatography	NULL
will	NULL
be	NULL
a	NULL
powerful	NULL
tool	NULL
for	NULL
the	NULL
purification	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
.	NULL

However	NULL
,	NULL
even	NULL
at	NULL
the	NULL
current	NULL
level	NULL
of	NULL
sophistication	NULL
,	NULL
the	NULL
availability	NULL
of	NULL
antibodies	NULL
that	NULL
recognize	NULL
glucocorticoid	NULL
receptors	NULL
will	NULL
undoubtedly	NULL
open	NULL
up	NULL
new	NULL
areas	NULL
of	NULL
research	NULL
on	NULL
these	NULL
important	NULL
regulatory	NULL
proteins	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Chan	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
O'Malley	NULL
,	NULL
B.	NULL
W.	NULL
Mechanism	NULL
of	NULL
action	NULL
of	NULL
the	NULL
sex	NULL
steroid	NULL
hormones	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
294	NULL
;	NULL
1322-1328	NULL
,	NULL
1976	NULL
.	NULL

2	NULL
.	NULL

Eisen	NULL
,	NULL
H.	NULL
J	NULL
.	NULL

An	NULL
antiserum	NULL
to	NULL
the	NULL
rat	NULL
liver	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A.	NULL
,	NULL
77	NULL
:	NULL
3893-3897	NULL
,	NULL
1980	NULL
.	NULL

3	NULL
.	NULL

Eisen	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
Glinsmann	NULL
,	NULL
W.	NULL
H.	NULL
Maximizing	NULL
the	NULL
purification	NULL
of	NULL
the	NULL
activated	NULL
glucocorticoid	NULL
receptor	NULL
by	NULL
DNA-cellulose	NULL
chromatography	NULL
.	NULL

Bio-chem	NULL
.	NULL

J.	NULL
,	NULL
171	NULL
;	NULL
177-183	NULL
,	NULL
1978	NULL
.	NULL

JANUARY	NULL
1981	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

Immunochemical	NULL
Studies	NULL
of	NULL
Glucocorticoid	NULL
Receptors	NULL
.	NULL

Govindan	NULL
,	NULL
M.	NULL
V.	NULL
Purification	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
from	NULL
rat	NULL
liver	NULL
cytosol	NULL
.	NULL

Preparation	NULL
of	NULL
antibodies	NULL
against	NULL
the	NULL
major	NULL
receptor	NULL
proteins	NULL
and	NULL
application	NULL
of	NULL
immunological	NULL
techniques	NULL
to	NULL
study	NULL
activation	NULL
and	NULL
translocation	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

,	NULL
11	NULL
:	NULL
323-332	NULL
,	NULL
1979.	NULL
.	NULL

Greene	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Closs	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
DeSombre	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
and	NULL
Jensen	NULL
,	NULL
E.	NULL
V.	NULL
Antibodies	NULL
to	NULL
estrophilin	NULL
:	NULL
comparison	NULL
between	NULL
rabbit	NULL
and	NULL
goat	NULL
antisera	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

,	NULL
11	NULL
:	NULL
333-341	NULL
,	NULL
1979.	NULL
.	NULL

Greene	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Fitch	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
and	NULL
Jensen	NULL
,	NULL
E.	NULL
V.	NULL
Monoclonal	NULL
antibodies	NULL
to	NULL
estrophilin	NULL
:	NULL
probes	NULL
for	NULL
the	NULL
study	NULL
of	NULL
estrogen	NULL
receptors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A.	NULL
,	NULL
77	NULL
:	NULL
157-161	NULL
,	NULL
1980.	NULL
.	NULL

Harmon	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Norman	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Fowlkes	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
E.	NULL
B.	NULL
Dexamethasone	NULL
induces	NULL
irreversible	NULL
G	NULL
,	NULL
arrest	NULL
and	NULL
death	NULL
of	NULL
a	NULL
human	NULL
lymphoid	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
98	NULL
:	NULL
267-278	NULL
,	NULL
1979.	NULL
.	NULL

Jensen	NULL
,	NULL
E.	NULL
V.	NULL
,	NULL
and	NULL
DeSombre	NULL
,	NULL
E.	NULL
R.	NULL
Steroid	NULL
hormone	NULL
receptors	NULL
in	NULL
breast	NULL
cancer	NULL
.	NULL

in	NULL
:	NULL
J.	NULL
R.	NULL
Pasqualini	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Receptors	NULL
and	NULL
Mechanism	NULL
of	NULL
Action	NULL
of	NULL
Steroid	NULL
Hormones	NULL
,	NULL
pp	NULL
.	NULL

569-601	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Marcel	NULL
Dekker	NULL
,	NULL
Inc.	NULL
,	NULL
1977.	NULL
.	NULL

Liao	NULL
,	NULL
S.	NULL
Receptors	NULL
and	NULL
the	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
androgens	NULL
.	NULL

in	NULL
:	NULL
J.	NULL
R.	NULL
Pasqualini	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Receptors	NULL
and	NULL
Mechanism	NULL
of	NULL
Action	NULL
of	NULL
Steroid	NULL
Hormones	NULL
,	NULL
pp	NULL
.	NULL

159-214	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Marcel	NULL
Dekker	NULL
,	NULL
Inc.	NULL
,	NULL
1976	NULL
.	NULL

Litwack	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Rosenfield	NULL
,	NULL
S.	NULL
A.	NULL
Liver	NULL
cytosol	NULL
corticosteroid	NULL
binder	NULL
IB	NULL
,	NULL
a	NULL
new	NULL
binding	NULL
protein	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
250	NULL
:	NULL
6799-6805	NULL
,	NULL
1975	NULL
.	NULL

Norman	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
E.	NULL
B	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
glucocorticoid-sensitive	NULL
human	NULL
lymphoid	NULL
cell	NULL
line	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
37	NULL
:	NULL
3785-3791	NULL
,	NULL
1977	NULL
.	NULL

Pasqualini	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Sumida	NULL
,	NULL
C.	NULL
Mineralocorticoid	NULL
receptors	NULL
in	NULL
target	NULL
tissues	NULL
.	NULL

in	NULL
:	NULL
J.	NULL
R.	NULL
Pasqualini	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Receptors	NULL
and	NULL
Mechanism	NULL
of	NULL
Action	NULL
of	NULL
Steroid	NULL
Hormones	NULL
,	NULL
pp	NULL
.	NULL

399-411	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Marcel	NULL
Dekker	NULL
,	NULL
Inc.	NULL
,	NULL
1977.	NULL
.	NULL

Rosen	NULL
,	NULL
F.	NULL
,	NULL
Kaiser	NULL
,	NULL
N.	NULL
,	NULL
Mayer	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Milholland	NULL
,	NULL
R.	NULL
J.	NULL
Glucocorticoids	NULL
:	NULL
receptors	NULL
and	NULL
mechanism	NULL
of	NULL
action	NULL
in	NULL
lymphoid	NULL
tissues	NULL
and	NULL
muscle	NULL
.	NULL

Methods	NULL
Cancer	NULL
Res	NULL
.	NULL

,	NULL
13	NULL
;	NULL
67-100	NULL
,	NULL
1976	NULL
.	NULL

Sedmak	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Grossberg	NULL
,	NULL
S.	NULL
E.	NULL
A	NULL
rapid	NULL
,	NULL
sensitive	NULL
,	NULL
and	NULL
versatile	NULL
assay	NULL
for	NULL
protein	NULL
using	NULL
Coomassie	NULL
brilliant	NULL
blue	NULL
G250	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
79	NULL
:	NULL
544-§52	NULL
,	NULL
1977	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
R.	NULL
Physical-chemical	NULL
analysis	NULL
of	NULL
steroid	NULL
hormone	NULL
receptors	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

,	NULL
36	NULL
:	NULL
211-234	NULL
,	NULL
1975	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Tuazon	NULL
,	NULL
F.	NULL
B.	NULL
,	NULL
and	NULL
Miller	NULL
,	NULL
L.	NULL
K.	NULL
Estrogen	NULL
receptor	NULL
cleavage	NULL
and	NULL
plasminogen	NULL
activation	NULL
by	NULL
enzymes	NULL
in	NULL
human	NULL
breast	NULL
tumor	NULL
cytosol	NULL
.	NULL

Endocrinology	NULL
,	NULL
106	NULL
:	NULL
1715-1727	NULL
,	NULL
1980	NULL
.	NULL

Stevens	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Stevens	NULL
,	NULL
Y.-W.	NULL
Physicochemical	NULL
differences	NULL
between	NULL
glucocorticoid-binding	NULL
components	NULL
from	NULL
the	NULL
corticoid-sensitive	NULL
and	NULL
-resistant	NULL
strains	NULL
of	NULL
mouse	NULL
lymphoma	NULL
P1798	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
39	NULL
:	NULL
4011-4021	NULL
,	NULL
1979.	NULL
.	NULL

Stevens	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Stevens	NULL
,	NULL
Y.-W	NULL
.	NULL

Influence	NULL
of	NULL
limited	NULL
proteolysis	NULL
on	NULL
the	NULL
physicochemical	NULL
and	NULL
DNA-binding	NULL
properties	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
from	NULL
corticoid-sensitive	NULL
and	NULL
-resistant	NULL
mouse	NULL
lymphoma	NULL
P1798	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
41	NULL
:	NULL
125-133	NULL
,	NULL
1981.	NULL
.	NULL

Stevens	NULL
,	NULL
J.	NULL
,	NULL
Stevens	NULL
,	NULL
Y.-W.	NULL
,	NULL
and	NULL
Hollander	NULL
,	NULL
V.	NULL
P.	NULL
Glucocorticoids	NULL
.	NULL

In	NULL
:	NULL
J	NULL
.	NULL

A.	NULL
Kellen	NULL
and	NULL
R.	NULL
Hilf	NULL
(	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
Influence	NULL
of	NULL
Hormones	NULL
in	NULL
Tumor	NULL
Development	NULL
,	NULL
Vol	NULL
.	NULL

2	NULL
,	NULL
pp	NULL
.	NULL

85-109	NULL
.	NULL

Boca	NULL
Raton	NULL
,	NULL
Fla.	NULL
:	NULL
CRC	NULL
Press	NULL
,	NULL
Inc.	NULL
,	NULL
1979	NULL
.	NULL

Stevens	NULL
,	NULL
J.	NULL
,	NULL
Stevens	NULL
,	NULL
Y.-W.	NULL
,	NULL
Rhodes	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Steiner	NULL
,	NULL
G.	NULL
Differences	NULL
in	NULL
nuclear	NULL
glucocorticoid	NULL
binding	NULL
between	NULL
corticoid-sensitive	NULL
and	NULL
corticoid-resistant	NULL
lymphocytes	NULL
of	NULL
mouse	NULL
lymphoma	NULL
P1798	NULL
and	NULL
stabilization	NULL
of	NULL
nuclear	NULL
hormone	NULL
receptor	NULL
complexes	NULL
with	NULL
carbobenzoxy-L-phenylalanine	NULL
.	NULL

J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

,	NULL
61	NULL
:	NULL
1477-1485	NULL
,	NULL
1978	NULL
.	NULL

Stevens	NULL
,	NULL
J.	NULL
,	NULL
Stevens	NULL
,	NULL
Y.-W.	NULL
,	NULL
and	NULL
Rosenthal	NULL
,	NULL
R.	NULL
L.	NULL
Characterization	NULL
of	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
glucocorticoid-binding	NULL
components	NULL
in	NULL
human	NULL
leukemic	NULL
lymphocytes	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
39	NULL
:	NULL
4939-4948	NULL
,	NULL
1979	NULL
.	NULL

Toft	NULL
,	NULL
D.	NULL
O.	NULL
,	NULL
and	NULL
Sherman	NULL
,	NULL
M.	NULL
R.	NULL
Receptor	NULL
identification	NULL
by	NULL
density	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

36	NULL
:	NULL
156-166	NULL
,	NULL
1975	NULL
.	NULL

Wrange	NULL
,	NULL
O.	NULL
,	NULL
Caristedt-Duke	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Gustafsson	NULL
,	NULL
J.-A	NULL
.	NULL

Purification	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
from	NULL
rat	NULL
liver	NULL
cytosol	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
254	NULL
:	NULL
9284-9290	NULL
,	NULL
1979	NULL
.	NULL

#	NULL
137	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1981	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

AAGR	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
Cancer	NULL
Research	NULL
The	NULL
Journal	NULL
of	NULL
Cancer	NULL
Research	NULL
(	NULL
1916-1930	NULL
)	NULL
|	NULL
The	NULL
American	NULL
Journal	NULL
of	NULL
Cancer	NULL
(	NULL
1931-1940	NULL
)	NULL
Immunochemical	NULL
Differences	NULL
between	NULL
Glucocorticoid	NULL
Receptors	NULL
from	NULL
Corticoid-sensitive	NULL
and	NULL
-resistant	NULL
Malignant	NULL
Lymphocytes	NULL
John	NULL
Stevens	NULL
,	NULL
Howard	NULL
J.	NULL
Eisen	NULL
,	NULL
Yee-Wan	NULL
Stevens	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Cancer	NULL
Res	NULL
1981	NULL
;	NULL
41:134-137	NULL
.	NULL

Updated	NULL
version	NULL
Access	NULL
the	NULL
most	NULL
recent	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/41/1/134	NULL
E-mail	NULL
alerts	NULL
Reprints	NULL
and	NULL
Subscriptions	NULL
Permissions	NULL
Sign	NULL
up	NULL
to	NULL
receive	NULL
free	NULL
email-alerts	NULL
related	NULL
to	NULL
this	NULL
article	NULL
or	NULL
journal	NULL
.	NULL

To	NULL
order	NULL
reprints	NULL
of	NULL
this	NULL
article	NULL
or	NULL
to	NULL
subscribe	NULL
to	NULL
the	NULL
journal	NULL
,	NULL
contact	NULL
the	NULL
AACR	NULL
Publications	NULL
Department	NULL
at	NULL
pubs	NULL
@	NULL
aacr.org	NULL
.	NULL

To	NULL
request	NULL
permission	NULL
to	NULL
re-use	NULL
all	NULL
or	NULL
part	NULL
of	NULL
this	NULL
article	NULL
,	NULL
use	NULL
this	NULL
link	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/41/1/1	NULL
34	NULL
.	NULL

Click	NULL
on	NULL
``	NULL
Request	NULL
Permissions	NULL
``	NULL
which	NULL
will	NULL
take	NULL
you	NULL
to	NULL
the	NULL
Copyright	NULL
Clearance	NULL
Center	NULL
's	NULL
(	NULL
CCC	NULL
)	NULL
Rightslink	NULL
site	NULL
.	NULL

Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1981	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

